RE:The report isn't bad at allquinlash wrote: They increased sales, slipped a little on margin however the margins they are reporting are way higher than recreational cannabis margins. One time write-downs / expenses would need to be reviewed by all to see what makes that up however the company is making moves to optimize operations etc so it shouldn't come as a big surprise. EBITDA timeline looks very promising assuming the company excutes properly on their plans.
Anyhow, that's my feedback after a quick review of the report
DYODD / GLTA
Q
You said it, ACB is stalling or declining like all the others. How will ACB grow with the competition? The population will double? ACB will launch a new product already produce by the competition? So they promise peanuts and you are all excited? If ACB reach its goal to be EBITDA at the end of 2022, it would be a first in the whole sector since they all failed on their promise. Only the naive would believe this. Then EBITDA? No, "ajusted EBITDA" and you know the meaning. Even the private companies, well managed are struggling too, too much competition. PS; quinpump is a pumper. He lured the naive Hexo investors from $14.00 to .26c.